The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Acadia Pharmaceuticals Inc | Common | 004225108 | 2,918 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| ADC Therapeutics, Inc. | Common | H0036K147 | 6,815 | 337,396 | SH | SOLE | 337,396 | 0 | 0 | ||
| Amicus Therapeutics Inc. | Common | 03152W109 | 5,929 | 513,333 | SH | SOLE | 513,333 | 0 | 0 | ||
| Avadel Pharmaceuticals Plc | Common | 05337M104 | 3,033 | 375,326 | SH | SOLE | 375,326 | 0 | 0 | ||
| AVROBIO, Inc. | Common | 05455M100 | 2,494 | 647,918 | SH | SOLE | 647,918 | 0 | 0 | ||
| Axsome Therapeutics Inc. | Common | 05464T104 | 3,907 | 103,405 | SH | SOLE | 103,405 | 0 | 0 | ||
| Biocryst Pharmaceuticals Inc. | Common | 09058V103 | 9,168 | 661,951 | SH | SOLE | 661,951 | 0 | 0 | ||
| Black Diamond Therapeutics, Inc. | Common | 09203E105 | 1,279 | 239,888 | SH | SOLE | 239,888 | 0 | 0 | ||
| Crinetics Pharmaceuticals Inc. | Common | 22663K107 | 10,790 | 379,792 | SH | SOLE | 379,792 | 0 | 0 | ||
| Cullinan Oncology, Inc. | Common | 230031106 | 118,013 | 7,648,268 | SH | SOLE | 7,648,268 | 0 | 0 | ||
| Cytokinetics Inc. | Common | 23282W605 | 10,587 | 232,268 | SH | SOLE | 232,268 | 0 | 0 | ||
| Epizyme, Inc. | Common | 29428V104 | 8,563 | 3,425,202 | SH | SOLE | 3,425,202 | 0 | 0 | ||
| ESSA Pharma, Inc. | Common | 29668H708 | 9,495 | 668,688 | SH | SOLE | 668,688 | 0 | 0 | ||
| G1 Therapeutics, Inc. | Common | 3621LQ109 | 8,748 | 856,798 | SH | SOLE | 856,798 | 0 | 0 | ||
| Geron Corporation | Common | 374163103 | 6,861 | 5,623,889 | SH | SOLE | 5,623,889 | 0 | 0 | ||
| Harmony Biosciences Hldgs Inc. | Common | 413197104 | 6,074 | 142,437 | SH | SOLE | 142,437 | 0 | 0 | ||
| Harpoon Therapeutics, Inc. | Common | 41358P106 | 24,135 | 3,196,707 | SH | SOLE | 3,196,707 | 0 | 0 | ||
| Inozyme Pharma Inc. | Common | 45790W108 | 2,064 | 302,615 | SH | SOLE | 302,615 | 0 | 0 | ||
| Intellia Therapeutics, Inc. | Common | 45826J105 | 18,981 | 160,527 | SH | SOLE | 160,527 | 0 | 0 | ||
| iTeos Therapeutics, Inc. | Common | 46565G104 | 85,890 | 1,844,727 | SH | SOLE | 1,844,727 | 0 | 0 | ||
| MEI Pharma, Inc. | Common | 55279B202 | 32,977 | 12,350,971 | SH | SOLE | 12,350,971 | 0 | 0 | ||
| Merus N.V. | Common | N5749R100 | 29,488 | 927,302 | SH | SOLE | 927,302 | 0 | 0 | ||
| Mirum Pharmaceuticals Inc. | Common | 604749101 | 4,767 | 298,852 | SH | SOLE | 298,852 | 0 | 0 | ||
| Neogenomics Inc. | Common | 64049M209 | 4,791 | 140,422 | SH | SOLE | 140,422 | 0 | 0 | ||
| Oncorus, Inc. | Common | 68236R103 | 12,527 | 2,377,031 | SH | SOLE | 2,377,031 | 0 | 0 | ||
| Repare Therapeutics, Inc. | Common | 760273102 | 34,584 | 1,639,849 | SH | SOLE | 1,639,849 | 0 | 0 | ||
| Revolution Medicines, Inc. | Common | 76155X100 | 3,676 | 146,041 | SH | SOLE | 146,041 | 0 | 0 | ||
| TCR2 Therapeutics, Inc. | Common | 87808K106 | 15,709 | 3,370,982 | SH | SOLE | 3,370,982 | 0 | 0 | ||
| Travere Therapeutics Inc. | Common | 89422G107 | 8,936 | 287,893 | SH | SOLE | 287,893 | 0 | 0 | ||
| Turning Point Therapeutics, Inc. | Common | 90041T108 | 12,943 | 271,350 | SH | SOLE | 271,350 | 0 | 0 | ||
| Verastem, Inc. | Common | 92337C104 | 6,707 | 3,271,532 | SH | SOLE | 3,271,532 | 0 | 0 | ||
| Werewolf Therapeutics, Inc. | Common | 95075A107 | 28,441 | 2,388,011 | SH | SOLE | 2,388,011 | 0 | 0 | ||
| YmAbs Therapeutics, Inc. | Common | 984241109 | 7,237 | 446,457 | SH | SOLE | 446,457 | 0 | 0 | ||